Indefinite Delivery Contract 75D30121D10576
Award Date
4/1/21
Last Date to Order
3/31/22
Federal Agency
CDC Pittsburgh
Awardee
Sanofi Pasteur Inc.
Ultimate Awardee
Not listed
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Other Statutory Authority
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This indefinite delivery contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to support pediatric immunization programs. The contract holder will provide up to 23 standard pediatric vaccines to CDC without a set-aside designation. Vaccines must be manufactured under current FDA licensure with a minimum 12-month shelf life. The multiple award IDV has a potential value of $1.5B to be ordered by March 2023 for delivery within the United...
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) to Pfizer Inc. for the purchase of 27 different pediatric vaccines to support the CDC's Immunization Awardees program and Vaccines for Children program. The contract has a period of performance from April 1, 2024 to March 31, 2025 and a ceiling value of $1,914,795,500.00. The solicitation sought offers for the supply of...
This indefinite delivery contract, awarded by the Centers for Disease Control and Prevention (CDC) to Glaxosmithkline, LLC, provides for the purchase of 20 different pediatric vaccines for the CDC's Vaccines for Children program. The contract has a $986,824,450 ceiling value and a period of performance from April 1, 2020 through March 31, 2021. Glaxosmithkline, as the prime contractor, will supply vaccines such as DTaP, Hep A and B, Hib, HPV, MMR, pneumococcal, rotavirus, and varicella in...
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) to Pfizer Inc. to provide a variety of standard pediatric vaccines to support immunization programs under the Vaccines for Children program and Section 317(j) of the Public Health Service Act. The IDC has a ceiling value of $1,598,247,500 and a period of performance from April 1, 2021 through March 31, 2022. It was...
This federal contract IDV is awarded by the Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) to procure a range of pediatric vaccines for the agency's Immunization Awardees program and Vaccines for Children program. The 5-year, $1.3 billion multiple award contract enables the CDC to purchase between 100 doses and 13 million doses of 27 different pediatric vaccines from the prime contractor, Glaxosmithkline, LLC. The vaccines must...
This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) to Pfizer Inc. to purchase a variety of pediatric vaccines for the Vaccines for Children (VFC) program. The $1.5 billion contract has a period of performance from April 1, 2023 to March 31, 2024. The contract will procure a minimum of 100 doses up to maximum quantities ranging from 100,000 to 13 million doses for 21...
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), a civilian federal agency, to Sanofi Pasteur Inc. as the prime contractor. The contract has a ceiling value of $144,427,500 and a period of performance from the award date of December 31, 2020 through February 28, 2022. The contract is for the provision of pediatric influenza vaccines, including a minimum order size of 100 doses and a maximum quantity of 50 million doses. The vaccines...
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Glaxosmithkline, LLC, a pharmaceutical company, to provide up to 23 standard pediatric vaccines. The $1.14 billion, multiple-award contract has a period of performance from April 1, 2022 to March 31, 2023 and supports pediatric immunization programs under Section 317(j) of the Public Health Service Act and the Vaccines for Children program. The vaccines, which must have a minimum...
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) to Grifols USA LLC, a global healthcare company and manufacturer of essential plasma-derived medicines and vaccines. The contract, valued at a ceiling of $12,409,500, is for the supply of 20 standard pediatric vaccines to support immunization programs under the Vaccines for Children (VFC) program and Section 317(j) of the...
This indefinite delivery contract, awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc., is for the provision of vaccines for the Vaccines for Children (VFC) program. Valued at up to $2,413,810,030, the 5-year contract (4/1/2023 - 3/31/2024) is a multiple award vehicle that allows the CDC to issue task orders for a variety of vaccine products and related services from the prime contractor. Sanofi Pasteur, as a leading global vaccine manufacturer, will leverage...